PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 6 filers reported holding PDL BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $36,000 | +24.1% | 10,685 | -23.1% | 0.00% | – |
| Q4 2016 | $29,000 | -98.1% | 13,887 | -92.9% | 0.00% | -100.0% |
| Q4 2014 | $1,510,000 | +5.7% | 195,848 | +2.2% | 0.02% | -4.2% |
| Q3 2014 | $1,429,000 | -46.2% | 191,723 | -30.1% | 0.02% | -47.8% |
| Q2 2014 | $2,656,000 | +10.6% | 274,361 | -5.1% | 0.05% | -2.1% |
| Q1 2014 | $2,402,000 | +119.6% | 289,068 | +123.0% | 0.05% | +113.6% |
| Q4 2013 | $1,094,000 | +13.7% | 129,630 | +49.9% | 0.02% | -8.3% |
| Q3 2013 | $962,000 | – | 86,460 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |